[144] SOPHiA GENETICS SA SEC Filing
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Jurgi Camblong reported multiple planned sales of Common Stock under a Rule 10b5-1 plan. The filing lists discrete 10b5-1 sale transactions across 2026 (example: 37,299 shares on 01/22/2026 for $209,917.83) and shows Restricted Stock Units (4,486) and Founders Shares (8,500) referenced.
Positive
- None.
Negative
- None.
Insights
Series of pre‑arranged 10b5‑1 dispositions reported; routine compliance filing.
The entries list repeated 10b5‑1 sales by Jurgi Camblong across multiple dates in 2026 with per‑trade share counts and gross proceeds. The filing also records RSUs (4,486) and Founders Shares (8,500) in the securities table.
These entries document sales activity under an automated plan; cash‑flow recipients and any post‑transaction holdings are not provided in the excerpt.